Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00981578 · ClinicalTrials.gov registry record · NA
ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain
A NA study, sponsored by InSightec.
- Terminated
- Registry status
- NA
- Development phase
- 37
- Enrollment target
NCT00981578 is a NA study that was terminated before completion, run by InSightec. The registered enrollment target is 37 participants.
The verdict
NCT00981578, a NA study, was terminated before completion, sponsored by InSightec.
- TERMINATED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
Study Summary
A study to evaluate the safety and initial effectiveness of the ExAblate 2100 Conformal Bone System in the treatment of pain resulting from metastatic bone tumors.
Interventions
- DEVICE ExAblate 2100
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2009-09 |
| Est. Completion | 2016-11-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00981578
The ClinicalTrials.gov registry entry for NCT00981578 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is InSightec, which has 38 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ExAblate 2100 is the first listed.
NCT00981578 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00981578 about?
NCT00981578 is a clinical study titled "ExAblate Conformal Bone System Treatment of Metastatic Bone Tumors for the Palliation of Pain". A study to evaluate the safety and initial effectiveness of the ExAblate 2100 Conformal Bone System in the treatment of pain resulting from metastatic bone tumors.
What is the current status of trial NCT00981578?
This trial is currently terminated. It is a NA study. The enrollment target is 37 participants. The study started on 2009-09. Estimated completion is 2016-11-14.
What interventions are being tested in trial NCT00981578?
The interventions under investigation include: ExAblate 2100 (DEVICE).
Who is sponsoring clinical trial NCT00981578?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.